Juntendo Medical Journal
Online ISSN : 2188-2126
Print ISSN : 2187-9737
ISSN-L : 2187-9737
Special Reviews: 354th Triannual Meeting of the Juntendo Medical Society “Recent topics in Psychiatry” [1]
Prevention of Delirium Via Melatonin and Orexin Neurotransmission
KOTARO HATTA
Author information
JOURNAL OPEN ACCESS

2022 Volume 68 Issue 1 Pages 12-16

Details
Abstract

The fundamental conception of delirium is altered arousal. In addition, sleep-wake cycle disturbances including insomnia, excessive daytime napping, and disintegration of the expected circadian patterns have been described as a characteristic component of delirium for decades, and demonstrated to be a core symptom domain of delirium. Although non-pharmacological interventions are successful to some extent, they have limitations due to various biological etiologies for delirium. Among pharmacological interventions, antipsychotics seem to be effective, but they are not suitable for preventive use because of relatively frequent side-effects such as extrapyramidal symptoms. Recently, new type of drugs for insomnia have been focused with respect to delirium prevention. Recent meta-analyses show effectiveness of melatonin receptor agonists and orexin receptor antagonists for delirium prevention, and real-world data support them.

Content from these authors
© 2022 The Juntendo Medical Society. This is an open access article distributed under the terms of Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original source is properly credited.

This article is licensed under a Creative Commons [Attribution 4.0 International] license.
https://creativecommons.org/licenses/by/4.0/
Previous article Next article
feedback
Top